Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
   D02 EMOLLIENTS AND PROTECTIVES
   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D05 ANTIPSORIATICS
   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
   D08 ANTISEPTICS AND DISINFECTANTS
   D09 MEDICATED DRESSINGS
   D10 ANTI-ACNE PREPARATIONS
     D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
       D10AA Corticosteroids, combinations for treatment of acne
       D10AB Preparations containing sulfur
       D10AD Retinoids for topical use in acne
       D10AE Peroxides
       D10AF Antiinfectives for treatment of acne
       D10AX Other anti-acne preparations for topical use
         D10AX01 Aluminium chloride
         D10AX02 Resorcinol [DG:DG00438]
           D00133  Resorcinol (USP) <JP>
           D02393  Resorcinol monoacetate (USP)
         D10AX03 Azelaic acid
         D10AX04 Aluminium oxide
         D10AX05 Dapsone
         D10AX06 Clascoterone
         D10AX30 Various combinations
     D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE
   D11 OTHER DERMATOLOGICAL PREPARATIONS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
   S01 OPHTHALMOLOGICALS
     S01A ANTIINFECTIVES
       S01AA Antibiotics
       S01AB Sulfonamides
       S01AD Antivirals
       S01AE Fluoroquinolones
       S01AX Other antiinfectives
         S01AX01 Mercury compounds
         S01AX02 Silver compounds [DG:DG00429]
         S01AX03 Zinc compounds
         S01AX04 Nitrofural
         S01AX05 Bibrocathol
         S01AX06 Resorcinol [DG:DG00438]
           D00133  Resorcinol (USP) <JP>
           D02393  Resorcinol monoacetate (USP)
         S01AX07 Sodium borate
         S01AX08 Hexamidine
         S01AX09 Chlorhexidine [DG:DG00001]
         S01AX10 Sodium propionate [DG:DG01126]
         S01AX14 Dibrompropamidine [DG:DG00423]
         S01AX15 Propamidine [DG:DG00424]
         S01AX16 Picloxydine
         S01AX18 Povidone-iodine
         S01AX24 Polihexanide
     S01B ANTIINFLAMMATORY AGENTS
     S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
     S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
     S01F MYDRIATICS AND CYCLOPLEGICS
     S01G DECONGESTANTS AND ANTIALLERGICS
     S01H LOCAL ANESTHETICS
     S01J DIAGNOSTIC AGENTS
     S01K SURGICAL AIDS
     S01L OCULAR VASCULAR DISORDER AGENTS
     S01X OTHER OPHTHALMOLOGICALS
   S02 OTOLOGICALS
   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 16, 2024
According to WHO's ATC 2024

» Japanese version